SE0400441D0 - Novel Benzofurans and Indols - Google Patents

Novel Benzofurans and Indols

Info

Publication number
SE0400441D0
SE0400441D0 SE0400441A SE0400441A SE0400441D0 SE 0400441 D0 SE0400441 D0 SE 0400441D0 SE 0400441 A SE0400441 A SE 0400441A SE 0400441 A SE0400441 A SE 0400441A SE 0400441 D0 SE0400441 D0 SE 0400441D0
Authority
SE
Sweden
Prior art keywords
sup
formula
methyl
trifluoromethyl
hydrogen
Prior art date
Application number
SE0400441A
Other languages
English (en)
Inventor
Eric Wellner
Helena Sandin
Original Assignee
Active Biotech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Active Biotech Ab filed Critical Active Biotech Ab
Priority to SE0400441A priority Critical patent/SE0400441D0/sv
Publication of SE0400441D0 publication Critical patent/SE0400441D0/sv
Priority to CA002552430A priority patent/CA2552430A1/en
Priority to CNA2004800419734A priority patent/CN1918122A/zh
Priority to AU2004316218A priority patent/AU2004316218A1/en
Priority to JP2007500071A priority patent/JP2007523920A/ja
Priority to ZA200605520A priority patent/ZA200605520B/en
Priority to EP04821685A priority patent/EP1718612A1/en
Priority to US10/995,037 priority patent/US7339059B2/en
Priority to PCT/EP2004/053058 priority patent/WO2005080336A1/en
Priority to US12/018,692 priority patent/US20080119485A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
SE0400441A 2004-02-25 2004-02-25 Novel Benzofurans and Indols SE0400441D0 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE0400441A SE0400441D0 (sv) 2004-02-25 2004-02-25 Novel Benzofurans and Indols
CA002552430A CA2552430A1 (en) 2004-02-25 2004-11-23 Novel benzofurans and indols
CNA2004800419734A CN1918122A (zh) 2004-02-25 2004-11-23 新的苯并呋喃类和吲哚类化合物
AU2004316218A AU2004316218A1 (en) 2004-02-25 2004-11-23 Novel benzofurans and indols
JP2007500071A JP2007523920A (ja) 2004-02-25 2004-11-23 新規ベンゾフランおよびインドール
ZA200605520A ZA200605520B (en) 2004-02-25 2004-11-23 Novel benzofurans and indols
EP04821685A EP1718612A1 (en) 2004-02-25 2004-11-23 Novel benzofurans and indols
US10/995,037 US7339059B2 (en) 2004-02-25 2004-11-23 Benzofurans and indols
PCT/EP2004/053058 WO2005080336A1 (en) 2004-02-25 2004-11-23 Novel benzofurans and indols
US12/018,692 US20080119485A1 (en) 2004-02-25 2008-01-23 Novel Benzofurans and Indols

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0400441A SE0400441D0 (sv) 2004-02-25 2004-02-25 Novel Benzofurans and Indols

Publications (1)

Publication Number Publication Date
SE0400441D0 true SE0400441D0 (sv) 2004-02-25

Family

ID=31989607

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0400441A SE0400441D0 (sv) 2004-02-25 2004-02-25 Novel Benzofurans and Indols

Country Status (9)

Country Link
US (2) US7339059B2 (sv)
EP (1) EP1718612A1 (sv)
JP (1) JP2007523920A (sv)
CN (1) CN1918122A (sv)
AU (1) AU2004316218A1 (sv)
CA (1) CA2552430A1 (sv)
SE (1) SE0400441D0 (sv)
WO (1) WO2005080336A1 (sv)
ZA (1) ZA200605520B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006060597A1 (de) * 2006-12-21 2008-06-26 Merck Patent Gmbh Verfahren zur Herstellung von Benzofuran-2-carboxamiden
UY32940A (es) 2009-10-27 2011-05-31 Bayer Cropscience Ag Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas
WO2012163848A1 (en) 2011-05-27 2012-12-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of crohn's disease
CN114507142A (zh) * 2022-01-28 2022-05-17 上海予君生物科技发展有限公司 一种2-氯-4-氟-5-硝基苯甲醛的制备工艺

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791501A (fr) * 1971-11-19 1973-05-17 Albert Ag Chem Werke Diamines cycliques n,n'-disubstituees et leur procede de preparation
US4115569A (en) 1971-11-19 1978-09-19 Hoechst Aktiengesellschaft Cyclic diamine derivatives
US4717653A (en) * 1981-09-25 1988-01-05 Webster John A Jr Method for identifying and characterizing organisms
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5374553A (en) * 1986-08-22 1994-12-20 Hoffmann-La Roche Inc. DNA encoding a thermostable nucleic acid polymerase enzyme from thermotoga maritima
US5185243A (en) * 1988-08-25 1993-02-09 Syntex (U.S.A.) Inc. Method for detection of specific nucleic acid sequences
US5075212A (en) * 1989-03-27 1991-12-24 University Of Patents, Inc. Methods of detecting picornaviruses in biological fluids and tissues
US5545522A (en) * 1989-09-22 1996-08-13 Van Gelder; Russell N. Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
US5268465A (en) * 1991-01-18 1993-12-07 The Johns Hopkins University Purification and molecular cloning of nitric oxide synthase
WO1993014217A1 (en) * 1992-01-10 1993-07-22 Life Technologies, Inc. Use of predetermined nucleotides having altered base pairing characteristics in the amplification of nucleic acid molecules
WO1993020234A1 (en) * 1992-03-31 1993-10-14 E.I. Du Pont De Nemours And Company A rapid, high capacity nucleic acid based assay
WO1994024105A1 (en) * 1993-04-15 1994-10-27 Merck Sharp & Dohme Limited Indole derivatives as dopamine d4 antagonists
US5585477A (en) * 1993-07-13 1996-12-17 Us Health Poliovirus specific primers
DE19545182C2 (de) * 1995-03-30 1998-09-17 Oji Paper Co Verfahren zur Herstellung von beschichtetem Papier
US6207665B1 (en) 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
DE60020143T2 (de) * 1999-03-31 2006-02-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Centers for Disease Control and Prevention, Office of Technology Transfer, Atlanta Typisierung von humanen enteroviren
UA72948C2 (uk) 1999-12-30 2005-05-16 Х. Луннбек А/С Заміщені похідні фенілпіперазину, фармацевтична композиція та спосіб лікування афективних або неврологічних захворювань і розладів
AU2001241927A1 (en) * 2000-02-28 2001-09-12 Scios Inc. Inhibitors of p38-alpha kinase
IL151923A0 (en) 2000-03-31 2003-04-10 Pfizer Prod Inc Novel piperazine derivatives
GB0224917D0 (en) 2002-10-25 2002-12-04 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
WO2005080336A1 (en) 2005-09-01
JP2007523920A (ja) 2007-08-23
ZA200605520B (en) 2007-11-28
AU2004316218A1 (en) 2005-09-01
CN1918122A (zh) 2007-02-21
US7339059B2 (en) 2008-03-04
US20080119485A1 (en) 2008-05-22
EP1718612A1 (en) 2006-11-08
CA2552430A1 (en) 2005-09-01
US20050192288A1 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
MX2010005753A (es) Derivados de isoxazolo-pirazina.
PE20040164A1 (es) Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas
RU2009109160A (ru) Инсектицидные изоксазолины
EA200600892A1 (ru) Новые хинолиновые производные
SE9801474D0 (sv) Quinoline Derivatives
MXPA03011638A (es) Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6.
NI200800008A (es) Métodos para la neuroprotección
AR035759A1 (es) Compuestos acilurea antagonistas de la funcion mpc-1, un procedimiento para su preparacion, composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos
ATE420859T1 (de) Azabicycloä3.1.0ühexylphenylderivate als modulatoren von dopamin-d3-rezeptoren
NO20080877L (no) Fremgangsmater for behandling av substansrelaterte forstyrrelser
RU2007125661A (ru) Арилоксиэтиламиновые и фенилпиперазиновые производные с сочетанием свойств неполного агонизма к рецепторам дофимина-d2 и ингибирования повторного поглощения серотонина
EA200970704A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ АНТАГОНИСТЫ NK1 РЕЦЕПТОРА И БЛОКАТОРЫ Na КАНАЛОВ
HRP20060009A2 (en) N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES, AND METHODS RELATED THERETO
AR035756A1 (es) Uso de carbamatos en la preparacion de medicamentos para la prevencion o tratamiento de trastornos neurodegenerativos
PT1202959E (pt) Aminobenzofenonas como inibidores de il-1-beta e tnf-alfa
EA200501148A1 (ru) Пиридилоксиметильные и бензизоксазольные азабициклические производные
ATE378046T1 (de) Carbamatverbindungen zur vorbeugung oder behandlung bipolarer erkrankungen
SE0303480D0 (sv) Benzofuranes
SE0400441D0 (sv) Novel Benzofurans and Indols
HK1062270A1 (en) Carbamate compounds for use in preventing or treating anxiety disorders
RS67503A (en) Carbamate compounds for use in preventing of treating psychotic disorders
ATE453621T1 (de) Substituierte 4-phenylpiperidinamide als tachykininantagonisten und serotoninwiederaufnahmehemmer
ATE389634T1 (de) Den vanilliod-trpv1-rezeptor antagonisierende sulfonamidoverbindungen
SE0400440D0 (sv) Novel Cinnamic Amides
DE60222879D1 (de) Cyclohexylphenyl vasopressin agonisten